Publications by authors named "Janet Lathey"

Claim this Profile
A
Availability and use of Standards in vaccine development.
Michael Selorm Avumegah, Giada Mattiuzzo, Anna Särnefält, Mark Page, Karen Makar, Janet Lathey

NPJ Vaccines· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced early innate and T cell-mediated responses in subjects immunized with Anthrax Vaccine Adsorbed Plus CPG 7909 (AV7909).
Jacob T Minang, Jon R Inglefield, Andrea M Harris, Janet L Lathey, David G Alleva

Vaccine· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of the native form of anthrax lethal factor for use in the toxin neutralization assay.
Hang Lu, Jason Catania, Katalin Baranji, Jie Feng, Mili Gu, Janet Lathey

Clin Vaccine Immunol· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term observation of adolescents initiating HAART therapy: three-year follow-up.
Patricia M Flynn, Bret J Rudy, Jane C Lindsey, Steven D Douglas, Janet Lathey

AIDS Res Hum Retroviruses· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Virologic and immunologic outcomes after 24 weeks in HIV type 1-infected adolescents receiving highly active antiretroviral therapy.
Patricia M Flynn, Bret J Rudy, Steven D Douglas, Janet Lathey, Stephen A Spector

J Infect Dis· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship of plasma HIV-1 RNA dynamics to baseline factors and virological responses to highly active antiretroviral therapy in adolescents (aged 12-22 years) infected through high-risk behavior.
Hulin Wu, Janet Lathey, Ping Ruan, Steven D Douglas, Stephen A Spector

J Infect Dis· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of baseline human immunodeficiency virus type 1 DNA measurement for disease progression in patients receiving nucleoside therapy.
Camlin Tierney, Janet L Lathey, Cindy Christopherson, Daniel M Bettendorf, Richard T D'Aquila

J Infect Dis· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of human immunodeficiency virus antigens as stimulants for lymphocyte proliferation assays.
John L Schmitz, Thomas N Denny, Ambrosia Garcia, Janet L Lathey,

Clin Diagn Lab Immunol· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of contaminating red blood cells on OKT3-mediated polyclonal activation of peripheral blood mononuclear cells.
Samuel Song, Joseph Goodwin, Jenny Zhang, Bruce Babbitt, Janet L Lathey

Clin Diagn Lab Immunol· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Encapsulated plasmid DNA treatment for human papillomavirus 16-associated anal dysplasia: a Phase I study of ZYC101.
Barbara Klencke, Mark Matijevic, Robert G Urban, Janet L Lathey, Mary Lynne Hedley

Clin Cancer Res· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis